Michael S. Bergwelt‐Baildon

Critical care management of chimeric antigen receptor T‐cell therapy recipients

É. Azoulay, A. Shimabukuro-Vornhagen, V. Metaxa, 2021 .

Engagement of CD83 ligand induces prolonged expansion of CD8 (cid:1) T cells and preferential enrichment for antigen specificity

D. Neuberg, G. Freeman, L. Nadler, 2006 .

Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome‐dependent cytosolic pathway in CD40‐activated B cells

S. Theurich, A. Shimabukuro-Vornhagen, E. Kondo, 2016, European journal of haematology.

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

P. Bartenstein, M. von Bergwelt-Baildon, J. Ricke, 2022, European Journal of Nuclear Medicine and Molecular Imaging.